Skip to main content
Clinical Trials/NCT06720506
NCT06720506
Not yet recruiting
Phase 4

Comparsion Between Intrathecal Fentanyl and Intravenous Nalbuphine As a Postoperative Analgesia in Lower Limb Surgeries

Assiut University0 sites100 target enrollmentJanuary 1, 2025

Overview

Phase
Phase 4
Intervention
fentanyl
Conditions
Lower Limb Surgery
Sponsor
Assiut University
Enrollment
100
Primary Endpoint
first request of rescue analgesia
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Postoperative pain management has been a major challenge and there has been great interest about it ., there have been persistent efforts to bring out the best possible analgesic technique with the least side effects. The popularity of lower limb surgeries owing to its higher incidence, orthopedic and vascular surgerise. Inadequate postoperative pain relief is associated with undesirable side effects resulting in chronic persistent pain, delayed recovery Concern about opioid has powerful effect in relief post operative pain.

the aim of this study is to Compare between fentanyl intrathecal and nalbuphine IV as a postoperative analgesia in lower limb surgeries

Detailed Description

Fentanyl, a potent lipid-soluble opioid which was first synthesized more than 40years ago, is still the most popular opioid used as post operative analgesia t. Fentanyl given intrathecally use in many acute and chronic pain conditions. inspite of its side effects fentanyl remains the mainstay of anesthesiologists in post operative period analgesia. Anesthetic methods of Lower limb surgery such as orthopedic and vascular surgeries, for example in the use of local infiltration, spinal anesthesia, caudal anesthesia, or general anesthesia Among them, spinal anesthesia is commonly used for lower limb surgery which does not need a sophisticated machine and which has been performed for years before anesthetic equipment such as mechanical ventilators and monitoring devices was produced. The development of new local anesthetic agents, the use of opioids, and an interest in acute and chronic pain management have universalized spinal anesthesia. Immediate pain is very severe in lowerlimb surgery and difficul to control. Moreover, due to the short hospitalization period, there is a limit in the application of patient-controlled analgesia that permits patients to treat pain by directly activating doses of opoids . Nalbuphine... Nalbuphine is an agonist-antagonist opioid and provides prolonged duration of analgesia with fewer side effects of fentanyl such as pruritus, nausea, and vomiting. Nalbuphine has a powerful effect in decreasing postoperative pain nNalbuphine IS asynthetic agonistant agonist opioid, demonstrated to attenuate mu-opioid receptor-related adverse events such as pruritis, nausea/emesis, constipation respiratory depression, undesirable sedation, and the development of toler ance and dependence. With several clinical reports, nalbuphine has been recognized as a safe and highly efficacious opioid analgesic that possesses remarkably low narcotic abuse liability. As a result, nalbuphine provides an alternative choice to replace strong opioids for the clinical practice of post- operative pain managemen

Registry
clinicaltrials.gov
Start Date
January 1, 2025
End Date
February 1, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Khaled Helmy Abdelbasser

resident doctor at Anathesia and icu department Faculty of Medicine, Assiut University

Assiut University

Eligibility Criteria

Inclusion Criteria

  • male and female pt between 18 and 600 year
  • pt with lower limb surgeries with no. Indication for general anathesia
  • patient with no contraindication for spinal anatthesia

Exclusion Criteria

  • pt who refuses
  • pt with hypersensivity to any drug
  • pt addicts opiods
  • chronic use of opiod
  • Inability to comprehend postoperatively the pain assessment scale/neuropsychiatric disorders.

Arms & Interventions

group F

patients will received intrathecal with dose 10-20ug

Intervention: fentanyl

group N

Nalbuphine will given IV as shot in. Dose 1mg /kg

Intervention: Nalbuphine

Outcomes

Primary Outcomes

first request of rescue analgesia

Time Frame: 24 hours

Duration of analgesia until first analgesic request

Similar Trials